Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05925959 · ClinicalTrials.gov registry record · NA

Preoperative Weight Loss for Open Abdominal Wall Reconstruction

A NA study of Abdominal Wall Hernia, sponsored by Benjamin T. Miller.

Recruiting
Registry status
NA
Development phase
258
Enrollment target
2
Study locations

NCT05925959 is a NA study of Abdominal Wall Hernia that is actively recruiting participants, run by Benjamin T. Miller. The registered enrollment target is 258 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05925959, a NA study of Abdominal Wall Hernia, is actively recruiting participants, sponsored by Benjamin T. Miller.

RECRUITING
Registry status
NA
Development phase
258 participants
Enrollment target
2
Study locations

Study Summary

The goal of this randomized controlled trial is to compare preoperative intensive weight management to upfront surgery in obese patients undergoing complex abdominal wall reconstruction. The main question is will abdominal wall specific quality of life (using the HerQLes survey) for the group undergoing upfront surgery be non-inferior compared to the group in the weight management program.

Conditions Studied

Interventions

  • OTHER Preoperative Weight Management Program

Study Locations (2)

Illinois

  • Northwestern University - Chicago

Ohio

  • Cleveland Clinic Main Campus - Cleveland

Trial Details

FieldValue
Enrollment Target 258 participants
Start Date 2023-06-19
Est. Completion 2027-06-01
Phase NA

Sponsor

Benjamin T. Miller

3 total trials

What the Registry Record Tells You About NCT05925959

The ClinicalTrials.gov registry entry for NCT05925959 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Benjamin T. Miller, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Abdominal Wall Hernia appearing as the primary indexed condition, and to 1 intervention - of which Preoperative Weight Management Program is the first listed.

NCT05925959 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Ohio.

Frequently Asked Questions

What is clinical trial NCT05925959 about?

NCT05925959 is a clinical study titled "Preoperative Weight Loss for Open Abdominal Wall Reconstruction". The goal of this randomized controlled trial is to compare preoperative intensive weight management to upfront surgery in obese patients undergoing complex abdominal wall reconstruction. The main question is will abdominal wall specific quality of life (using the HerQLes survey) for the group underg...

What is the current status of trial NCT05925959?

This trial is currently recruiting. It is a NA study. The enrollment target is 258 participants. The study started on 2023-06-19. Estimated completion is 2027-06-01.

What conditions does trial NCT05925959 study?

This clinical trial studies the following conditions: Abdominal Wall Hernia.

What interventions are being tested in trial NCT05925959?

The interventions under investigation include: Preoperative Weight Management Program (OTHER).

Who is sponsoring clinical trial NCT05925959?

This trial is sponsored by Benjamin T. Miller, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05925959 being conducted?

This trial has 2 study locations across Illinois, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Abdominal Wall Hernia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.